|
|
 |
|
|
|
|
[Portfolio review and analysis] |
|
|
|
|
|
|
|
|
decision trees, 35-37 |
|
|
|
|
|
|
|
|
influence diagrams, 35, 36 |
|
|
|
|
|
|
|
|
Monte Carlo simulation, 36-38 |
|
|
|
|
|
|
|
|
multiattribute analysis, 37-39 |
|
|
|
|
|
|
|
|
option pricing analysis, 38, 39 |
|
|
|
|
|
|
|
|
three elements to balance in, 26, 27 |
|
|
|
|
|
|
|
|
Product requirement specification for development of drug delivery devices, 196, 197 |
|
|
|
|
|
|
|
|
Program manager |
|
|
|
|
|
|
|
|
differences between project manager and, 82 |
|
|
|
|
|
|
|
|
Project management in the defense industry, 82-100 |
|
|
|
|
|
|
|
|
control of projects, 83-100 |
|
|
|
|
|
|
|
|
assessment of projects, 84, 85 |
|
|
|
|
|
|
|
|
background and situation status, 83, 84 |
|
|
|
|
|
|
|
|
critical success factors, 86 |
|
|
|
|
|
|
|
|
framework of control, 92-97 |
|
|
|
|
|
|
|
|
management of change, 85, 86 |
|
|
|
|
|
|
|
|
organizational structure, 87-92 |
|
|
|
|
|
|
|
|
outcome, 98-100 |
|
|
|
|
|
|
|
|
work breakdown structure, 86, 87 |
|
|
|
|
|
|
|
|
Project planning, 51-80 |
|
|
|
|
|
|
|
|
basis of the project plan, 53-57 |
|
|
|
|
|
|
|
|
defining the project target, 53-57 |
|
|
|
|
|
|
|
|
legal and regulatory requirements, 57 |
|
|
|
|
|
|
|
|
difference of planning in research and in development, 53 |
|
|
|
|
|
|
|
|
IT as aid to, 281 |
|
|
|
|
|
|
|
|
the planning process, 52 |
|
|
|
|
|
|
|
|
[Project Planning] |
|
|
|
|
|
|
|
|
planning tools and system support, 72-80 |
|
|
|
|
|
|
|
|
information systems, 77-80 |
|
|
|
|
|
|
|
|
network plans, 72, 73 |
|
|
|
|
|
|
|
|
the standard plan, 73-77 |
|
|
|
|
|
|
|
|
preparing the plan, 57-72 |
|
|
|
|
|
|
|
|
elements of the plan, 57, 58 |
|
|
|
|
|
|
|
|
first plan, 58-63 |
|
|
|
|
|
|
|
|
management of the process, 71, 72 |
|
|
|
|
|
|
|
|
optimizing the plan, 61-70 |
|
|
|
|
|
|
|
|
stepwise planning and decision points, 70, 71 |
|
|
|
|
|
|
|
|
Project teams, 91, 92 |
|
|
|
|
|
|
|
|
Protocol construction and progress for clinical research projects, 206, 207 |
|
|
|
|
|
|
|
|
R&D |
|
|
|
|
|
|
|
|
building high-performance teams for, 274, 275 |
|
|
|
|
|
|
|
|
portfolio review and analysis of R&D feasibility, 30 |
|
|
|
|
|
|
|
|
See also Contracted clinical R&D |
|
|
|
|
|
|
|
|
R&D alliances. See Joint ventures |
|
|
|
|
|
|
|
|
Request for a proposal and budget quotation (RFP) from the CRO, 172 |
|
|
|
|
|
|
|
|
Research phase of drug development, 53 |
|
|
|
|
|
|
|
|
Research potential, 29, 30 |
|
|
|
|
|
|
|
|
Resource management/capacity planning |
|
|
|
|
|
|
|
|
IT and, 281 |
|
|
|
|
|
|
|
|
Resources, 30, 31 |
|
|
|
|
|
|
|
|
Return on investment (ROI), 39, 42 |
|
|
|
|
|
|
|
|
Rewards for achievement of key project goals |
|
|
|
|
|
|
|
|
managing an international project team and, 118, 119 |
|
|
|
|
|